The New York Academy of Sciences CEO and leadership

Douglas Braaten was senior editor at Nature Immunology before taking the helm of Annals in January 2009. Douglas joined the Nature group in 2005 after completing a postdoctoral research fellowship in viral immunology in the Department of Pathology and Immunology at Washington University in St. Louis; this research included evaluating CD8+ T cell responses to chronic gammaherpesvirus infection using the mouse model Gammaherpesvirus 68. Douglas earned his Ph.D. in virology at the College of Physicians and Surgeons of Columbia University in 2000, working on molecular biology of HIV infection of T cells and on understanding the required association of the cytoplasmic protein Cyclophilin A with the Gag protein of HIV-1, an association essential for HIV-1 infectivity. Earlier, Douglas served as staff associate and senior research staff assistant in the microbiology and biology departments of Columbia University from 1990 to 1996, working on Drosophila genetics, the retrotransposable element copia, and on molecular biology of HIV-1. Doug earned a bachelors degree in biology at Washington University in 1984, and studied in the M.D. program at OU School of Medicine, the Masters of Liberal Arts program at Washington University in St. Louis, and the Ph.D. program in philosophy at Columbia University at various points in his career.

I use my voice and platform to engage and educate people about the positive impact of science on people and our planet. As a scientist and communications executive, I connect stakeholders from academia, industry, government, and public sectors in focused efforts to catalyze advances in science, medicine, engineering, and innovation for the benefit and education of society. Building on a PhD in life sciences, and broad area knowledge from physical sciences and chemistry to engineering and sustainability, my unique cross-functional experience encompasses nonprofit executive management, science publishing, donor cultivation and management, content and brand-related digital product development, consulting, and marketing.

Currently Chief Scientific Officer at the New York Academy of Sciences-among the oldest scientific organizations in the United States-I build, scale, and lead teams, programs, and products spanning the US, UK, Israel, and Japan in support of scientists and science enthusiasts alike. I previously oversaw editorial management and scientific content creation at The Journal of Clinical Investigation. As a brand ambassador, spokesperson, and keynote speaker I engage audiences at colleges, conferences, events, and corporations, as well as through print and broadcast media, about the latest technical and medical innovations-bringing the future to your doorstep.

Senior leader with strong business experience in financial and operational management, investment portfolio management, cash management, strategic planning, capital budgeting and financing, facilities and real estate development, information systems, auditing and risk management, and human resources. Over 20 years of experience in education, and government. Positions held include: Vice President of Finance and Administration, CFO, Treasurer, Head of Performance/Change Management, Internal Consulting, and Procurement Officer.

Known for taking an entreupenureal approach in both creating and implementing business transformation initiatives that reduce costs, increase revenues and mitigate risk. A thought leader, with very strong analytical skills, technology innovator who is internally motivated and builds and retains high performing teams.

Select Areas of Expertise:

- Asset Allocation, Manager Sourcing and Due Due Diligence

- Debt Financing

- Investment and Portfolio Management

- Real Estate Acquisitions

- Financial Planning & Analysis

- Strategic Planning

- Perfomance Budgeting

- Data Analysis and Data Warehousing

- Financial Systems Development

- Insurance & Risk Management

- Banking & Cash Management

- Human Resources

- Information Systems

- Procurement

- Real Estate

- Education and Government

Strategic finance professional with 12+ years of experience encompassing corporate development, private equity consulting, investment banking, and global capital markets. Skilled in partnering with C-suite and business unit leadership to develop best-in-class corporate finance and operational capabilities. Adept at operating in both public and private company settings with strength in financial strategy implementation, transaction execution, change management, investor / sponsor engagement, and value realization.

• Key player in execution of 25+ debt, equity, M&A, and capital allocation strategy transactions across all major sectors

• Developer of value-creation strategies within high growth Private Equity / Venture Capital-backed companies

Editorial Board are an Annals Editor-in-Chief: Douglas Braaten Ph at New York Academy Of Sciences and are based in © the New York Academy of Sciences.

Douglas Braaten was senior editor at Nature Immunology before taking the helm of Annals in January 2009. Douglas joined the Nature group in 2005 after completing a postdoctoral research fellowship in viral immunology in the Department of Pathology and Immunology at Washington University in St. Louis; this research included evaluating CD8+ T cell responses to chronic gammaherpesvirus infection using the mouse model Gammaherpesvirus 68. Douglas earned his Ph.D. in virology at the College of Physicians and Surgeons of Columbia University in 2000, working on molecular biology of HIV infection of T cells and on understanding the required association of the cytoplasmic protein Cyclophilin A with the Gag protein of HIV-1, an association essential for HIV-1 infectivity. Earlier, Douglas served as staff associate and senior research staff assistant in the microbiology and biology departments of Columbia University from 1990 to 1996, working on Drosophila genetics, the retrotransposable element copia, and on molecular biology of HIV-1. Doug earned a bachelors degree in biology at Washington University in 1984, and studied in the M.D. program at OU School of Medicine, the Masters of Liberal Arts program at Washington University in St. Louis, and the Ph.D. program in philosophy at Columbia University at various points in his career.